GENOWAY |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.08 EUR | +1.24% |
|
-0.49% | -11.30% |
| 2023 | GenOway: sharp rise, broker initiates buy recommendation | CF |
| 2023 | GENOWAY : Euroland initiates buy coverage | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GENOWAY | Other Biotechnology & Medical Research | +1.24% | -0.49% | -11.30% | +3.29% | +161.54% | 38.79M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- ALGEN Stock
- Charts genOway
- Comparison Chart
